Mimedx Group logo

Mimedx Group Share Price Today

(NASDAQ: MDXG)

Mimedx Group share price is $8.09 & ₹703.58 as on 6 Mar 2025, 2.30 'hrs' IST

$8.09

-0.01

(-0.12%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Mimedx Group share price in Dollar and Rupees. Guide to invest in Mimedx Group stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mimedx Group, along with analyst recommendations, forecasts, and comprehensive financials.

Mimedx Group share price movements

  • Today's Low: $8.01
    Today's High: $8.21

    Day's Volatility :2.44%

  • 52 Weeks Low: $5.47
    52 Weeks High: $10.14

    52 Weeks Volatility :46.06%

Mimedx Group (MDXG) Returns

PeriodMimedx Group, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-14.47%
2.1%
0.0%
6 Months
26.96%
-4.1%
0.0%
1 Year
0.37%
2.2%
0.0%
3 Years
67.7%
11.8%
-11.6%

Mimedx Group (MDXG) Key Statistics

in dollars & INR

Previous Close
$8.1
Open
$8.07
Today's High
$8.205
Today's Low
$8.005
Market Capitalization
$1.2B
Today's Volume
$279.2K
52 Week High
$10.14
52 Week Low
$5.47
Revenue TTM
$348.9M
EBITDA
$65.4M
Earnings Per Share (EPS)
$0.28
PE Ratio
29.64
Profit Margin
12.16%
Quarterly Earnings Growth YOY
-0.86%
Return On Equity TTM
25.01%

How to invest in Mimedx Group Stock (MDXG) from India?

It is very easy for Indian residents to invest directly in Mimedx Group from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mimedx Group stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mimedx Group or MDXG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mimedx Group or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mimedx Group shares which would translate to 0.108 fractional shares of Mimedx Group as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mimedx Group, in just a few clicks!

Returns in Mimedx Group (MDXG) for Indian investors in Rupees

The Mimedx Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mimedx Group investment value today

Current value as on today

₹1,05,211

Returns

₹5,211

(+5.21%)

Returns from Mimedx Group Stock

₹248 (+0.25%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Mimedx Group (MDXG)

233%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Mimedx Group Stock from India on INDmoney has increased by 233% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Mimedx Group

  • Essex Woodlands Health Ventures

    19.13%

  • BlackRock Inc

    6.51%

  • Trigran Investments Inc

    5.17%

  • Vanguard Group Inc

    4.55%

  • Paradigm Capital Management, Inc.

    3.18%

  • Cannell Capital LLC

    2.47%

Analyst Recommendation on Mimedx Group

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Mimedx Group(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Mimedx Group Stock (MDXG)

What analysts predicted

Upside of 65.64%

Target:

$13.40

Current:

$8.09

Insights on Mimedx Group Stock (Ticker Symbol: MDXG)

  • Price Movement

    In the last 7 days, MDXG stock has moved up by 1.1%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 84.05M → 92.90M (in $), with an average increase of 9.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 17.62M → 7.43M (in $), with an average decrease of 31.1% per quarter
  • MDXG vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 61.1%
  • Price to Sales

    ForMDXG every $1 of sales, investors are willing to pay $3.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Mimedx Group Technicals Summary

Sell

Neutral

Buy

Mimedx Group is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Mimedx Group (MDXG) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mimedx Group, Inc. logo
-5.15%
26.96%
0.37%
67.7%
12.03%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mimedx Group, Inc. logo
29.64
29.64
2.97
0.27
0.25
0.15
NA
1.31
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mimedx Group, Inc. logo
Buy
$1.2B
12.03%
29.64
12.16%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Mimedx Group

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.
Organization
Mimedx Group
Employees
837
CEO
Mr. Joseph H. Capper
Industry
Biotechnology

Management People of Mimedx Group

NameTitle
Mr. Joseph H. Capper
CEO & Director
Mr. Douglas C. Rice CPA
Chief Financial Officer
Mr. William F. Hulse IV
General Counsel & Chief Administrative Officer
Mr. Scott M. Turner
Senior Vice President of Operations & Procurement
Mr. Matthew M. Notarianni
Head of Investor Relations
Mr. Mark P. Graves
Senior VP & Chief Compliance Officer
Ms. Hilary Dixon
Vice President of Investor Relations & Corporate Strategic Communications
Ms. Kate Surdez
Chief Human Resources Officer
Dr. David H. Mason Jr.
Chief Medical Officer
Dr. Robert Benjamin Stein M.D., Ph.D.
President of Regenerative Medicine & Biologics Innovation

Important FAQs about investing in MDXG Stock from India :

What is Mimedx Group share price today?

Mimedx Group share price today stands at $8.09, Open: $8.07 ; Previous Close: $8.10 ; High: $8.21 ; Low: $8.01 ; 52 Week High: $10.14 ; 52 Week Low: $5.47.

The stock opens at $8.07, after a previous close of $8.10. The stock reached a daily high of $8.21 and a low of $8.01, with a 52-week high of $10.14 and a 52-week low of $5.47.

Can Indians buy Mimedx Group shares?

Yes, Indians can invest in the Mimedx Group (MDXG) from India.

With INDmoney, you can buy Mimedx Group at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Mimedx Group at zero transaction cost.

How can I buy Mimedx Group shares from India?

It is very easy to buy Mimedx Group from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mimedx Group (MDXG) be purchased?

Yes, you can buy fractional shares of Mimedx Group with INDmoney app.

What are the documents required to start investing in Mimedx Group stocks?

To start investing in Mimedx Group, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mimedx Group Stock (MDXG)?

Today’s highest price of Mimedx Group (MDXG) is $8.21.

Today’s lowest price of Mimedx Group (MDXG) is $8.01.

What is today's market capitalisation of Mimedx Group?

Today's market capitalisation of Mimedx Group MDXG is 1.2B

What is the 52 Week High and Low Range of Mimedx Group Stock (MDXG)?

  • 52 Week High

    $10.14

  • 52 Week Low

    $5.47

What are the historical returns of Mimedx Group (MDXG)?

  • 1 Month Returns

    -5.15%

  • 3 Months Returns

    26.96%

  • 1 Year Returns

    0.37%

  • 5 Years Returns

    12.03%

Who is the Chief Executive Officer (CEO) of Mimedx Group ?

Mr. Joseph H. Capper is the current Chief Executive Officer (CEO) of Mimedx Group.